Circulation Journal Official Journal of the Japanese Circulation Society http://www. j-circ.or.jp iabetic nephropathy ranks as the leading etiology of end-stage renal disease (ESRD) requiring hemodialysis. 1 Cardiovascular complications largely account for the morbidity and mortality among such patients. 2 More than the most common cardiovascular alteration in ESRD, left ventricular (LV) hypertrophy is also an independent risk factor for survival. 3 As is well known, patients with diabetes mellitus (DM) are more prone to LV hypertrophy, coronary heart disease and impaired LV function. 4 As a distinguishing feature of the disease, diabetic cardiomyopathy is characterized by chronic inflammation, myocardial damage secondary to a metabolic insult, reactive hypertrophy and intermediary fibrosis, structural and functional changes of the small coronary vessels, interference with the management of the metabolic cardiovascular load, and cardiac autonomic neuropathy leading to heart failure. 5-8Altered cardiac structure and function are commonly found in asymptomatic patients with type 2 DM, even in the absence of hypertension and coronary artery disease. Echocardiography, an excellent non-invasive and imaging modality, defines cardiac structure and function. Early studies showed that half of the diabetic patients with decreased myocardial diastolic function remained undiagnosed on conventional echocardiography. 9 This inability is attributed to echocardiographic subestimation of the degree of diastolic dysfunction of 60% in subjects with normal arterial blood pressure. Under-diagnosis of the diastolic dysfunction may also occur in ESRD patients on maintenance hemodialysis with DM. Recent studies using tissue Doppler imaging (TDI) have contributed to the evaluation of diastolic function.